This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Animal Health and Veterinary Biologicals Development
At BioVenic, we are dedicated to advancing animal healthcare through a full spectrum of biotechnological solutions. From custom cell development to therapeutic biologics, vaccines, and precision nutrition services, we support scientists, veterinarians, and biotech companies in accelerating veterinary research and improving the lives of animals. Our unique value lies in the combination of robust technical platforms, a multidisciplinary team, and a one-stop service model tailored to specific animal species.
Animal Health and Veterinary Biologicals Development Service
BioVenic delivers comprehensive custom animal cell solutions designed for advanced veterinary and biomedical research. We offer primary cells, mesenchymal and embryonic stem cells, immune cells, and immortalized lines tailored to specific animal species. Leveraging 3D cell culture and organoid technologies, our models closely mimic in vivo environments. Each cell product is validated through stringent quality control processes—covering identity, purity, and functionality—ensuring reproducibility and high performance in disease modeling, drug screening, and regenerative applications.
Veterinary Biological Therapeutics Development
Our veterinary therapeutic development services cover the full pipeline for biologics targeting companion animals and livestock. We apply advanced technologies such as hybridoma screening, single B-cell sorting, phage display, and CRISPR gene editing to create monoclonal antibodies, peptides, and proteins. For cell-based therapies, we utilize stem cell engineering, immune cell manipulation, and biomaterial integration. Each candidate undergoes detailed structural and functional validation, followed by preclinical testing to ensure reduced immunogenicity and enhanced therapeutic efficacy.
Veterinary Vaccine Development
BioVenic provides end-to-end veterinary vaccine development solutions against viruses, bacteria, protozoa, fungi, parasites, and rickettsia. We use cutting-edge platforms such as gene-deleted attenuated strains, recombinant subunit antigens, nucleic acid vaccines (DNA, mRNA), VLPs, and phage vectors. Our expertise includes innovative vaccines for immunocastration and companion animal oncology. We support all stages from antigen discovery to in vivo efficacy testing, ensuring strong, species-specific immune protection and compliance with veterinary safety standards.
Animal Nutrition and Feed Development
We offer a comprehensive suite of services for animal nutrition and feed development across livestock, poultry, aquaculture, and companion animals. Our capabilities include in vitro and in vivo modeling of digestion, absorption, and metabolism, with omics integration for deeper insight. We specialize in formulating safe, functional feeds through fermentation, enzymatic processing, and additive development. Services also include mycotoxin and ANF detection, palatability improvement, and food safety assessment—ensuring health, productivity, and nutritional precision.
Service Workflow for Animal Health and Veterinary Biologicals Development
We follow a structured yet flexible workflow to support clients from concept development through to final data delivery and manufacturing.
Fig.1 Animal health and veterinary biologicals development service workflow. (BioVenic Original)
Advanced Technical Platforms for Veterinary Biologics
BioVenic's suite of technologies provides clients with access to cutting-edge tools that streamline the development of veterinary biologics and nutritional solutions. Our integrated platform approach ensures flexibility, scalability, and efficiency in every project.
| Area | Key Technologies and Capabilities |
|---|---|
| Antibody & Protein Engineering | Hybridoma, Phage Display, Single B-cell Sorting, Fc Optimization, CRISPR, Next-Generation Sequencing |
| Vaccine Development | Recombinant DNA/RNA, Live Attenuated and Toxoid Platforms, VLPs, Phage Vectors, Subunit Vaccines |
| Cell Therapy & Modeling | Stem Cell Culture (MSCs, iPSCs), Immune Cell Engineering, Organoid Systems, Synthetic Biology |
| Nutrition & Metabolism | In Vitro Digestion and Fermentation Models, Omics Profiling (Metabolomics, Transcriptomics), Hormonal Assays |
Advantages of Our Animal Health and Veterinary Biologicals Development Service
Deep Scientific Expertise
Our cross-functional team of scientists possesses deep expertise in fields including molecular biology, veterinary medicine, bioengineering, and animal nutrition. This diversity allows us to offer highly customized and scientifically rigorous solutions.
Innovation-Driven Platform
We continually invest in the latest technologies—from CRISPR genome editing and recombinant vaccine platforms to advanced omics and AI-supported modeling—ensuring that your project benefits from the most modern and effective techniques.
Animal-Centered Customization
We understand the physiological and metabolic diversity across animal species. Our service platforms are designed with flexibility to support species-specific models and research goals, from livestock to aquatic species and companion animals.
Rigorous Quality Control
Each project at BioVenic is executed under stringent quality control standards. From sterility testing and identity verification to safety validation and regulatory documentation, we ensure your results are both reliable and reproducible.
Partner with BioVenic to unlock the future of veterinary innovation. Whether you're exploring new cell models, developing next-generation vaccines, or optimizing animal nutrition, our integrated solutions offer the support, precision, and insight you need to succeed. Contact us to discover how we can help bring your veterinary research.
FAQs
What makes BioVenic's cell models different from standard commercial cell lines?
Our models include primary and stem cells directly isolated from animal tissues, with optional 3D organoid formats. These better replicate in vivo environments compared to immortalized standard lines.
Can you support development of vaccines for zoonotic diseases?
Yes. Our platforms can develop vaccines targeting zoonotic pathogens, with dual-use capabilities for animal and human safety models.
What kinds of nutritional models can you create?
We offer in vitro digestion and fermentation models, metabolic disorder simulation, and species-specific in vivo trials for swine, bovine, poultry, canine, feline, equine, and aquatic species.
References
- Slavny, Peter, et al. "Advancements in mammalian display technology for therapeutic antibody development and beyond: current landscape, challenges, and future prospects." Frontiers in Immunology 15 (2024): 1469329. https://doi.org/10.3389/fimmu.2024.1469329
- Huangfu, Weikang, et al. "In vitro and in vivo fermentation models to study the function of dietary fiber in pig nutrition." Applied Microbiology and Biotechnology 108.1 (2024): 314. https://doi.org/10.1007/s00253-024-13148-9